Real World Exposure-Response Relationship of Vedolizumab in Inflammatory Bowel Disease: A Pooled Multicenter Observational Cohort Analysis of Clinical and Modeled Pharmacological Data

被引：0

作者：

Vande Casteele, Niels ^{[1
]}

Sandborn, William J. ^{[1
]}

Feagan, Brian G. ^{[2
,3
,4
]}

Vermeire, Severine ^{[5
]}

Dulai, Parambir S. ^{[1
]}

Panes, Julian ^{[6
]}

Yarur, Andres ^{[7
]}

Roblin, Xavier ^{[8
]}

Ben-Horin, Shomron ^{[9
,10
]}

Dotan, Iris ^{[11
]}

Osterman, Mark ^{[12
]}

Lindner, Dirk ^{[13
]}

Agboton, Christian ^{[13
]}

Rosario, Maria ^{[14
]}

Osborn, Teresa ^{[15
]}

机构：

[1] Univ Calif San Diego, La Jolla, CA 92093 USA

[2] Robarts Clin Trials Inc, Amsterdam, Netherlands

[3] Acad Med Ctr, Amsterdam, Netherlands

[4] Western Univ, London, ON, Canada

[5] Univ Hosp Leuven, Leuven, Vlaams Brabant, Belgium

[6] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Catalonia, Spain

[7] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[8] Ctr Hosp Univ St Etienne, St Etienne, Auvergne, France

[9] Sheba Med Ctr, Tel Hashomer, Israel

[10] Tel Aviv Univ, Tel Aviv, Israel

[11] Rabin Med Ctr, Tel Aviv, Israel

[12] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[13] Takeda, Zurich, Switzerland

[14] Takeda, Cambridge, MA USA

[15] Takeda, Chicago, IL USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S0652

引用

页码：S327 / S327

页数：1

共 50 条

[21] Real-world data on the efficacy and safety of vedolizumab therapy in patients with inflammatory bowel disease: a retrospective nation-wide cohort study in Singapore
Gan, A. T. -M.
Chan, W. P. -W.
Ling, K. L.
Hartono, L. J.
Ong, D. E.
Gowans, M.
Lin, H.
Lim, W. C.
Tan, M. T. -K.
Ong, J. P. -L.
Schwender, B. J.
Kong, S. C.
Ong, W. C.
Lim, T. G.
Chuah, S. W.
Ooi, C. J.
Shim, H. H.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S434 - S435
[22] Real world experience of the transition from the intravenous to subcutaneous formulation of vedolizumab in inflammatory bowel disease: A review of current data
Agboton, C.
Kamble, P.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 835 - 836
[23] REAL WORLD EXPERIENCE OF THE TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS FORMULATION OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: CURRENT DATA REVIEW
Robertson, James
Kamble, Pravin
Agboton, Christian
GUT, 2023, 72 (SUPPL_2) : A108 - A108
[24] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
Stefan Schreiber
Axel Dignass
Laurent Peyrin-Biroulet
Greg Hather
Dirk Demuth
Mahmoud Mosli
Rebecca Curtis
Javaria Mona Khalid
Edward Vincent Loftus
Journal of Gastroenterology, 2018, 53 : 1048 - 1064
[25] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
Schreiber, Stefan
Dignass, Axel
Peyrin-Biroulet, Laurent
Hather, Greg
Demuth, Dirk
Mosli, Mahmoud
Curtis, Rebecca
Khalid, Javaria Mona
Loftus, Edward Vincent, Jr.
JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1048 - 1064
[26] REAL-WORLD TRENDS IN CLINICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS INITIATING VEDOLIZUMAB OVER TIME IN ISRAEL
Weil, C.
Chodick, G.
Shalev, V
Demuth, D.
Petrakis, I
Ben Baruch, O.
Tsukinovsky, S.
Yarden, A.
VALUE IN HEALTH, 2018, 21 : S142 - S142
[27] VEDOLIZUMAB DOSE ESCALATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE EXPERIENCING LOSS OF RESPONSE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF REAL-WORLD EVIDENCE
Varghese, Della
Patel, Dipen
Martin, Stephan
Luo, Michelle
Ursos, Lyann
Lirio, Richard A.
Wang, Song
GASTROENTEROLOGY, 2020, 158 (06) : S406 - S407
[28] Vedolizumab dose escalation in patients with inflammatory bowel disease experiencing loss of response: A systematic review and meta-analysis of real-world evidence
Varghese, D.
Patel, D.
Martin, S.
Luo, M.
Ursos, L.
Lirio, R.
Wang, S.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S524 - S525
[29] Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study
Wiken, Thea H.
Hoivik, Marte L.
Anisdahl, Karoline
Buer, Lydia
Warren, David J.
Bolstad, Nils
Hagen, Milada
Moum, Bjorn A.
Medhus, Asle W.
CROHNS & COLITIS 360, 2024, 6 (01)
[30] Treatment persistence and clinical outcomes of vedolizumab in inflammatory bowel disease patients in Taiwan: real-world evidence from the TSIBD registry
Tai, Wei-Chen
Tu, Chia-Hung
Chou, Jen-Wei
Feng, I-Che
Chung, Chen-Shuan
Shieh, Ming-Jium
Yen, Hsu-Heng
Hsu, Wen-Hung
Lu, Chien-Yu
Lu, Lung-Sheng
Tang, Shu-Lun
Lien, Pei-Wen
Ye, Yizhou
Dolin, Paul
Wei, Shu-Chen
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 305 - 305

← 1 2 3 4 5 →